Sign in

Susan Cross

Independent Director at SiriusPoint
Board

About Susan L. Cross

Independent Class I director at SiriusPoint Ltd. (SPNT), age 65, appointed May 24, 2024. Over 40 years in (re)insurance, formerly EVP & Global Chief Actuary at XL Group (now AXA XL) and currently an Audit Committee financial expert. Holds a B.S. in Mathematics (University of Maryland); Fellow of the Casualty Actuarial Society, Chartered Enterprise Risk Analyst, and Associate of the Society of Actuaries; recognized among “100 Influential Women in Re/insurance.”

Past Roles

OrganizationRoleTenureCommittees/Impact
XL Group (now AXA XL)Executive Vice President & Global Chief Actuary2008–2018Led actuarial/analytical functions supporting global growth
IFG CompaniesDirectorNot disclosedPrior board service
American Strategic InsuranceDirectorNot disclosedPrior board service
Mid Ocean LimitedDirectorNot disclosedPrior board service
XL Life Ltd.DirectorNot disclosedPrior board service

External Roles

OrganizationRoleTenureNotes
Enstar Group Limited (Nasdaq: ESGR)DirectorSince Oct 2020Public company board
Unum Group (NYSE: UNM)Non-Executive DirectorCurrentPublic company board

Board Governance

  • Independence: Affirmatively determined independent (NYSE rules) in Feb 2025.
  • Committees: Audit (member; designated “audit committee financial expert”) and Risk & Capital Management (member).
  • Attendance: 100% Board and committee attendance in 2024.
  • Executive sessions: Independent/non-management directors met in executive session at regularly scheduled meetings; four executive sessions in 2024.
  • Board meetings in 2024: 5 formal Board meetings; Audit 4 formal; Risk & Capital Management 4 formal.

Fixed Compensation

ComponentPolicy/Amount2024 ActualNotes
Annual cash retainer (Independent directors)$137,500$83,065Prorated from appointment date (May 24, 2024)
Committee chair fees$35,000 (Audit, Risk & Capital Mgmt); $20,000 (Investment, Compensation, Governance & Nominating)$0Cross was not a committee chair in 2024
Non-Exec Chair / Lead Independent Director fees$100,000 / $50,000$0Not applicable
Meeting feesNot disclosedNot disclosedPolicy emphasizes retainers/equity; no meeting fees listed

Performance Compensation

Award TypeGrant DateNumber of SharesGrant-date Fair Value ($)Vesting
Restricted Shares (annual director grant)May 21, 202410,528137,500Vest on May 31, 2025, subject to continued service
OptionsNone for directors in 2024
Performance-based equity (PSUs)Directors receive time-based restricted shares, not PSUs

Performance metric framework for directors: none; director equity is time-based and intended for alignment/retention, not performance measurement.

Other Directorships & Interlocks

CompanyRolePotential Interlock/Conflict
Enstar Group LimitedDirectorNo SPNT-related party transactions disclosed with Enstar
Unum GroupNon-Executive DirectorNo SPNT-related party transactions disclosed with Unum
  • Overboarding policy: Directors should not serve on >4 other public boards; all current directors comply. Audit Committee members should not serve on >2 other public audit committees; Board states compliance.

Expertise & Qualifications

  • Actuarial and risk: Fellow of CAS; CERA; ASA; deep actuarial leadership experience.
  • Industry: 40+ years across global (re)insurance; executive leadership at AXA XL/XL Group.
  • Governance/financial literacy: Designated “audit committee financial expert.”
  • Education/recognition: B.S. Mathematics (University of Maryland); “100 Influential Women in Re/insurance.”

Equity Ownership

MetricValueNotes
Total beneficial ownership (common shares)10,5280.01% of outstanding common shares
Unvested restricted shares (12/31/2024)10,528Scheduled to vest 5/31/2025
Vested shares (12/31/2024)0Based on unvested count disclosure
Options (exercisable/unexercisable)NoneNo option awards for directors in 2024
Shares pledged/hedgedProhibited by policyCompany prohibits hedging and pledging by directors; no exceptions disclosed
Ownership guideline3x annual cash retainerDirectors must meet within 5 years; all independent directors achieved or on track

Governance Assessment

  • Board effectiveness: Cross strengthens Audit and Risk oversight; designated “audit committee financial expert” and actuarial background are positives for financial reporting and ERM. Attendance and independence support governance quality.
  • Alignment: Director compensation mix skews to equity (approx. 62% equity, 38% cash in 2024), promoting alignment with shareholders; ownership guidelines further enhance alignment.
  • Conflicts/related parties: Proxy details extensive transactions with CM Bermuda and Third Point; no disclosures involving Cross—no related-party transactions identified for her.
  • Risk indicators: Hedging/pledging prohibition reduces misalignment risk; Section 16(a) filing compliance achieved for directors/officers in 2024. No red flags on attendance or compensation anomalies for Cross.

RED FLAGS: None identified relating to Cross (no related-party transactions, pledging, or low attendance disclosed).